Pharos Vaccine
Seongnam
About Pharos Vaccine
Pharos Vaccine is a biotechnology firm that designs, develops, and manufactures advanced regenerative medicines for cell and gene therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $53.7M
- Funding stage: Early Stage Venture
- Last round: Series B (Feb 2022)
- Website: pharosvaccine.com
Industries & Categories
Biopharma, Biotechnology, Manufacturing
Canonical: https://fsome.com/organization/pharos-vaccine-38045 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.